StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis YoY Growth in the U.S. by Quarter

YoY Growth in the U.S. (% USD / cc) (%)

QuarterlyAnnual

Novartis YoY Growth in the U.S.: 78.0% in Q3 2026, up 82.0 pts from a year earlier. That is the highest of the 25 quarters on record here.

Latest, Q3 2026
78.0%
Period ended Sep 30, 2026
Change on a year earlier
+82.0 pts
-4.0% in Q3 2025
History
25 quarters
Since Q3 2020
Sources
25
Documents cited below

Where the Q3 2026 figure comes from

“|| Zolgensma Group | Neuroscience | Spinal muscular atrophy (SMA) | 173 | 78 | 231 | 13 | 14 | 404 | 34 | 35”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedYoY Growth in the U.S. (% USD / cc) (%)Year on yearSource
Q3 2026Sep 30, 202678.0%+82.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202658.0%+86.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026-9.0%-33.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025-5.0%-12.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025-4.0%-17.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 2025-28.0%-88.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202524.0%+29.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 20247.0%+16.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202413.0%+23.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202460.0%+92.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 2024-5.0%-1.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 2023-9.0%+6.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 2023-10.0%+11.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 2023-32.0%-48.0 ptsNovartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 2023-4.0%+1.0 ptsNovartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022-15.0%-26.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis YoY Growth in the U.S. (%), quarterly Q3 2020–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-zolgensma-group-us-yoy-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.